Armata Pharmaceuticals, Inc. Common Stock (ARMP)
SG&A Expense Growth
51.20%
Quarterly · Period ending:
ARMP SG&A Expense Growth
Latest reported51.20%period ending
Latest reported51.20%period ending
ARMP Quarterly SG&A Growth (QoQ) (0.00% → 51.20%)
Latest values, visible window
High-resolution chart · PNG
ARMP sg&a expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 14.2857% | |
| 0% | |
| 16.6667% | |
| -25% | |
| -11.1111% | |
| 12.5% | |
| 33.3333% | |
| 0% | |
| 0% | |
| 50% | |
| -20% | |
| -28.5714% | |
| 40% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |